Did some calcs and some reading. Feel free to add or correct.
So... Vince sold Anacor to Pfizer for 5.2 billion $USD in Jun 2016, which was for an eczema gel that reached phase 3.
Taking a USD inflation calculator, this is 6.82 billion $USD in today's value.
If Vince meets this previous achievement (not even beat it right), noting we got 1.81 billion shares on issue, this is a SP of $3.77 USD or $5.61 AUD for BOT.
We don't have a phase 3 drug; we got better. We got an FDA approved drug. Imagine what that means for BOT's future.
BOT - Anything but charting, page-11144
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.8¢ | 32.0¢ | $3.160M | 9.427M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 670399 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 24177 | 3 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |